Abstract
The pharmacokinetics and metabolism of [14C]rosaramicin were studied in dogs after intravenous (i.v.; 10 mg/kg [bodyweight]) and oral (25 mg/kg) administration. After i.v. administration, rosaramicin levels in plasma declined rapidly, with half-lives of 0.22 h for the distribution phase and 0.97 h for the elimination phase. The apparent volume of distribution was 3.43 liters/kg, and the total body clearance was 106 mg/min . kg, indicating extensive distribution in tissue or metabolism or both. The absorption of oral solution was 58%, and the absolute bioavailability of rosaramicin was 35%. The plasma area under the curve of unchanged rosaramicin was only 5% that of total radioactivity after oral administration and 8% after i.v. administration, indicating extensive metabolism of the drug. The total radioactivity excreted in urine accounted for only 24% of the i.v. dose and 17% of the oral dose. Fecal radioactivity accounted for 71% of the i.v. dose and 68% of the oral dose. Several metabolites were observed in the plasma and urine. The amount of unchanged rosaramicin in urine (1 to 2% of the dose) was quite small after drug administration by either route.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baumueller A., Hoyme U., Madsen P. O. Rosamicin--a new drug for the treatment of bacterial prostatitis. Antimicrob Agents Chemother. 1977 Aug;12(2):240–242. doi: 10.1128/aac.12.2.240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hoyme U., Baumueller A., Madsen P. O. Antibiotics excretion in canine vaginal and urethral secretions. Invest Urol. 1978 Jul;16(1):35–38. [PubMed] [Google Scholar]
- Lin C. C., Chung M., Gural R., Schuessler D., Kim H. K., Radwanski E., Marco A., DiGiore C., Symchowicz S. Pharmacokinetics and metabolism of rosaramicin in humans. Antimicrob Agents Chemother. 1984 Oct;26(4):522–526. doi: 10.1128/aac.26.4.522. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lin C., Kim H., Schuessler D., Oden E., Symchowicz S. High-pressure liquid chromatographic method for determination of rosaramicin in humans. Antimicrob Agents Chemother. 1980 Nov;18(5):780–783. doi: 10.1128/aac.18.5.780. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lin C., Puar M. S., Schuessler D., Prananik B. N., Symchowicz S. Isolation and identification of a metabolite of rosaramicin in human urine. Drug Metab Dispos. 1984 Jan-Feb;12(1):51–56. [PubMed] [Google Scholar]
- Madsen P. O., Baumueller A., Hoyme U. Experimental models for determination of antimicrobials in prostatic tissue, interstitial fluid and secretion. Scand J Infect Dis Suppl. 1978;(14):145–150. [PubMed] [Google Scholar]
- Wagman G. H., Waitz J. A., Marquez J., Murawaski A., Oden E. M., Testa R. T., Weinstein M. J. A new Micromonospora-produced macrolide antibiotic, rosamicin. J Antibiot (Tokyo) 1972 Nov;25(11):641–646. doi: 10.7164/antibiotics.25.641. [DOI] [PubMed] [Google Scholar]
- Waitz J. A., Drube C. G., Moss E. L., Jr, Weinstein M. J. Biological studies with rosamicin, a new Micromonospora-produced macrolide antibiotic. J Antibiot (Tokyo) 1972 Nov;25(11):647–652. doi: 10.7164/antibiotics.25.647. [DOI] [PubMed] [Google Scholar]